Centrosomes are central regulators of mitosis that are often amplified in cancer cells. Centrosomes function both as organizers of the mitotic spindle and as reaction centers to trigger activation of Cdk1 and G 2 /M transition in the cell cycle, but their functional organization remains incomplete. Recent proteomic studies have identified novel components of the human centrosome including Cep63, a protein of unknown function that Xenopus studies have implicated in mitotic spindle assembly and spindle inactivation after DNA damage. Here, we report that human Cep63 binds to and recruits Cdk1 to centrosomes, and thereby regulates mitotic entry. RNAi-mediated Cep63 depletion in U2OS cancer cells induced polyploidization through mitotic skipping. Elicitation of this phenotype was associated with downregulation of centrosomal Cdk1, mimicking the phenotype induced by direct depletion of Cdk1. In contrast, Cep63 overexpression induced de novo centrosome amplification during cell-cycle interphase. Induction of this phenotype was suppressible by cell treatment with the Cdk inhibitor roscovitine. In a survey of 244 neuroblastoma cases, Cep63 mRNA overexpression was associated with MYCN oncogene amplification and poor prognosis. In cultured cells, Cep63 overexpression was associated with an enhancement in replication-induced DNA breakage. Together, our findings define human Cep63 as a centrosomal recruitment factor for Cdk1 that is essential for mitotic entry, providing a physical link between the centrosome and the cell-cycle machinery. Cancer Res; 71(6); 2129-39. Ó2011 AACR.
Introduction
Centrosomes function as microtubule-organizing centers and mitotic spindle poles, directing the formation of bipolar spindles (1, 2) . To ensure spindle bipolarity, centrosomes normally duplicate precisely once per cell cycle, which occurs in parallel with DNA replication and is mediated by Cdk2 (1) (2) (3) (4) (5) (6) . Centrosome amplification has been frequently observed in both solid and hematologic malignancies and has been linked to tumorigenesis (7) . Both the preferred mechanism leading to and the relevant consequences of centrosome amplification are still controversial. Although Cdk2-dependent de novo synthesis of supernumerary centrosomes in interphase has been repeatedly postulated, centrosome amplification might alternatively result from polyploidization due to mitotic defects, or centrosomes might become fragmented (e.g., after DNA damage) rather than amplified (8) (9) (10) (11) (12) (13) (14) . Moreover, a centrosome inactivation checkpoint has been postulated where amplification (or fragmentation) of centrosomes in response to DNA damage leads to elimination of damaged cells via mitotic catastrophe (8) (9) (10) (11) (12) . On the other hand, in most cases, centrosome amplification does not induce widespread multipolar mitoses due to clustering of multiple centrosomes into a bipolar spindle array (15, 16) . Rather, amplified centrosomes lead to low-level chromosomal instability caused by increased chromosome missegregation rates (17) .
Centrosomes serve as reaction centers where key regulators meet to control cell-cycle transitions (8, 18) . In particular, the G 2 /M transition is initiated by the activation of cyclin B1-Cdk1 at centrosomes, which is stimulated by Cdc25B and Aurora A but inhibited by centrosomal Chk1 (19) (20) (21) (22) (23) . Similarly, cyclin E has been shown to localize to centrosomes, thereby promoting S-phase entry (24) . Spatiotemporal orchestration of centrosome and DNA replication cycles with mitotic events are essential for both proper cell proliferation and maintenance of chromosomal integrity (1, 2, 8) .
In a mass spectrometry-based proteomic screen for novel centrosomal components, Cep63 was among the most abundant newly identified proteins (25) . In a study on Xenopus mitotic egg extracts, Cep63 was shown to be targeted by ATM-and ATR-dependent phosphorylation, leading to inactivation of centrosome-dependent spindle assembly in response to DNA double-strand breaks (DSB; ref. 26 ). Our present study documents the first functional analysis of Cep63 in mammalian cells. We describe a novel function of Cep63 in recruiting the key mitotic kinase Cdk1 to centrosomes and report on chromosomal instability and ploidy aberrations in human cells with disbalanced levels of Cep63, including cancer-associated overexpression that correlates with poor patient prognosis.
Materials and Methods

Plasmid construction
Transcript variant 3 of Cep63 was provided by E.A. Nigg, variant 2 was purchased from ImaGenes (clone ID: IRALp962H1854Q2), other variants were produced by RT-PCR from BJ cells. All cDNAs were cloned into pEGFP-C1 (BD Biosciences Clontech). For stable transfection, pEGFPCep63 (transcript variant 3) was cloned into a modified pcDNA4/TO (Invitrogen) vector whose selection cassette was changed from zeocin to puromycin.
Cell culture, cell lines, and siRNAs EBV-transformed lymphoblastoid cells (provided by L. Savelyeva), KE-37, and CCRF-CEM cells were cultured in RPMI 1640 (Gibco) and other cell lines were cultured in DMEM (PAA Laboratories Inc.), each supplemented with 10% fetal calf serum (Biochrom) and antibiotics. Cell line contaminations were excluded according to published methodology (27) . Peripheral blood mononuclear cells of a healthy donor and a patient with chronic lymphocytic leukemia (CLL) were obtained by gradient centrifugation (Biocoll, 1.077 g/mL; Biochrom). Transfections were done using Oligofectamine (Invitrogen), Dharmafect (Thermo Scientific), or Fugene 6 (Roche). T-Rex-U2OS cells (Invitrogen) stably expressing GFP-Cep63 inducible by 1 mg/mL tetracycline was generated using a modified T-REx system (Invitrogen). The following siRNAs were used: 5 0 -GGCUCUGGCUGAACAAUCAdTdT-3 0 , targeting exon 6 of Cep63, 5 0 -gaacuucgucauccaaauadTdT-3 0 , targeting Cdk1, and 5 0 -UAAGGCUAUGAA GAGAUACdTdT-3 0 , targeting luciferase.
Antibodies
A GST-fusion peptide corresponding to exons 2 to 8 of Cep63 expressed from pGEX-4T-1 (Amersham Biosciences) was used to generate a mouse monoclonal IgG 1 antibody (DCS 390) by standard hybridoma technology, which showed specificity for immunostaining, immunoblotting, and immunoprecipitation (Figs. 1B and C and 2A; Supplementary Figs. S2B , E, S3A, and S7). Other antibodies used were mouse monoclonals to g-tubulin (TU-30; Exbio), Eg5 (BD Transduction Laboratories), Cdk1 (clone 17; Santa Cruz), centrin (20H5; provided by J.L. Salisbury), Cep170 (77-419; provided by E.A. Nigg), C-Nap1 (clone 42; BD Transduction Laboratories); GFP (B-2; Santa Cruz), phospho-Ser139 histone H2AX (g-H2AX; JBW301; Upstate), rabbit polyclonals to g-tubulin (T 5192; Sigma), actin (I-19 or C4; Santa Cruz), GFP (FL; Santa Cruz), pericentrin (ab4448; Abcam), phospho-Ser10 histone H3 (Upstate #06-570), and a rabbit monoclonal to Myc-tag (71D10; Cell Signaling).
Immunofluorescence, metaphase spreads, and live cell imaging
Standard protocols were applied for immunofluorescence of cells grown on coverslips or collected by cytocentrifugation (Shandon Cytospin 3) and for metaphase spreads. C in a humidified atmosphere containing 5% CO 2 , using a Zeiss Cell Observer (DKFZ Light Microscopy Facility) or the Nikon BioStation IM system (Nikon Imaging Centre).
Microinjection
Microinjection of siRNAs (final concentration 25-80 mmol/ L) and rhodamine B isothiocyanate-dextran (average mol wt 20,000; Sigma-Aldrich; final concentration 0.5%, w/v) was conducted on an Olympus IX70 microscope with a semiautomatic Eppendorf microinjection system (Microinjector 5242 and Micromanipulator 5171). All experiments included Cep63-siRNA and control luciferase siRNA-injected cells in 2 distinct areas on the same dish featuring a grid pattern to relocate injected cells. All injected cells were individually traced to determine cell fates. Cell sizes were measured after manual delineation of cell boundaries using, AxioVision 4.7.2 software (Zeiss).
Quantification of centrosomal proteins
Using a Zeiss LSM 710 laser scanning microscope (Zeiss Application Center), 3-dimensional confocal data sets from a defined volume containing the centrosome (verified by g-tubulin staining) were collected under standardized settings. The volume of signals exceeding a standardized threshold was calculated using AxioVision 4.7.2 software (Zeiss).
GST pulldown assay, immunoprecipitation, centrosome extraction, and immunoblotting
The cDNA of Cdk1 (transcript variant 3, encoding isoform 1) cloned into pcDNA3.1/Myc-His (Invitrogen) was subjected to in vitro transcription/translation with 35 S-labeling by using the TNT Quick Coupled Transcription/Translation System (Promega) following the manufacturer's instructions. In vitro GST pulldown assays using a GST-fusion peptide corresponding to full-length Cep63 (transcript variant 3) expressed from pGEX-4T-1 (Amersham Biosciences), immunoprecipitation using a 1:1 mixture of protein A-agarose and protein G-agarose (Roche), centrosome extraction from KE-37 cells, and immunoblotting were carried out following established protocols (28, 29) . If not indicated otherwise, control fractions for immunoprecipitates (bound) were 5% of the input protein extract and 5% of the supernatant from the immunoprecipitation reaction (unbound).
Flow cytometry
Standard protocols were applied for staining of cells with propidium iodide (Molecular Probes) with or without staining for phospho-Ser10-histone H3. Cells were subjected to flow cytometry by using a FACScan (BD Biosciences) flow cytometer.
Expression analysis of neuroblastoma samples
Cep63 mRNA expression in primary neuroblastomas was analyzed using oligo microarray as described (30, 31) .
DNA DSB analysis
Twenty-four hours after induction of GFP-Cep63 expression, cells were synchronized by thymidine (3 mmol/L, 24 hours) and released into medium containing 2-deoxycytidine (24 mmol/L) and, where indicated, aphidicolin (0.4 mmol/L). When cells started entering mitosis, colcemide was added (1 mg/mL). Eight hours later, metaphase spreads were prepared as described (32) . Following g-H2AX staining and image acquisition under standardized settings by using an Olympus BX50 fluorescent microscope equipped with a Cool Snap HQ2 digital camera (Photometrix), g-H2AX foci in metaphases were analyzed as described (Supplementary Fig. S8 ; ref. 33 ).
Statistical analysis
If not indicated otherwise, results are given as mean AE SD. Significances were determined using the heteroscedastic, 2-tailed Student t test or the c 2 test. To identify a model describing the relationship between survival and Cep63 expression, the functional form of the relationship was tested by maximally selected log-rank statistics (30) .
Results
Cep63 is a constitutive centrosomal protein
Consistent with the initial report (25) , transiently expressed GFP-Cep63 almost exclusively localized to centrosomes in several cell lines, with no differences among isoforms (Supplementary Figs. S1 and S2A). Since quantitative RT-PCR revealed that among the 4 known transcript variants variant 3 was most abundant (Supplementary Fig. S1B ), we used this variant to generate U2OS cells stably expressing GFP-Cep63 in a tetracycline-dependent manner and found GFP-Cep63 virtually exclusively localized to centrosomes in all cell-cycle phases (Fig. 1A) . Immunostaining with a mouse monoclonal antibody revealed that endogenous Cep63 almost exclusively localized to centrosomes throughout the cell cycle in all cell lines tested ( Fig. 1B; Supplementary Fig. S2B and C) . This pattern remained unaltered upon microtubule disruption ( Supplementary Fig. S2D ), confirming Cep63 to be a constitutive centrosomal protein. The centrosomal localization was verified by examining centrosome extracts, and in a panel of human normal, immortalized, and tumor cell lines, endogenous Cep63 was always present, with 2 prominent bands corresponding to isoforms 2 (63 kDa) and 3 (58 kDa) on immunoblots (Fig. 1C) . In immunofluorescence analyses, the number of Cep63 signals regularly matched the number of g-tubulin or pericentrin signals, respectively (Fig. 1A, B , and D). Detailed colocalization analysis by laser scanning Figure 2 . Cep63 downregulation induces polyploidization. A, U2OS cells were transfected with siRNA to luciferase (Luc) or Cep63, respectively, harvested after 72 hours, and immunostained for Cep63 (green) and g-tubulin (red). DNA was counterstained with DAPI (blue). Scale bars, 10 mm. B, U2OS cells were transfected with siRNA to luciferase (Luc) or Cep63, respectively, for 72 hours. After propidium iodide staining, the DNA content was measured by flow cytometry. C, metaphase spreads of U2OS cells were prepared 72 hours after transfection with siRNA to luciferase (Luc) or Cep63, respectively. Scale bars, 20 mm. Cancer Researchmicroscopy revealed that GFP-Cep63 mostly localized within the region positive for g-tubulin and pericentrin while showing a partial overlap with C-Nap1 but only little overlap with centrin and Cep170 (Fig. 1D ), indicating that Cep63 is a centrosomal but probably not core centriolar protein.
Cep63 downregulation induces polyploidization due to mitotic skipping Using a siRNA targeting all known isoforms of Cep63 ( Fig. 2A; Supplementary Figs . S2E and S3A and B), we depleted Cep63 in U2OS cells and found a striking accumulation of giant cells ( Fig. 2A; Supplementary Fig. S3C ). By 72 hours posttransfection, flow cytometry revealed a significant increase of cells with more than 4N DNA from 3.5% AE 0.4% in luciferase-siRNA-treated cells to 11.0% AE 2.0% after treatment with Cep63-siRNA (P ¼ 0.019; mean AE SD of 3 independent experiments). When only cells with 8N DNA were counted, this increase was likewise significant (P ¼ 0.021) with 1.6% AE 0.3% of cells after luciferase-siRNA but 6.3% AE 1.3% of cells after Cep63-siRNA harboring 8N DNA (Fig. 2B) . This phenotype was confirmed by using an alternative siRNA against Cep63 (Supplementary Fig. S3D and E; Supplementary Table S1). Polyploidization was further confirmed by a significant increase (P ¼ 0.010) of metaphases harboring diplochromosomes to 4.0% AE1.0% (mean AE SD of 3 times 100 metaphase spreads) 72 hours after treatment with Cep63-siRNA, a 12-fold increase compared with 0.3% AE 0.6% of metaphases after control luciferase-siRNA (Fig. 2C) .
To differentiate between skipping of mitosis, failed mitosis, or cell fusion underlying polyploidization, we conducted time-lapse video microscopy after direct microinjection of siRNA to Cep63 into U2OS cells. In repeated sessions using a variety of conditions and compassing up to 72 hours postmicroinjection, we observed neither cell fusions nor increased rates of aberrant or failed mitoses in Cep63-depleted cells compared with cells injected with luciferase-siRNA. Instead, the majority of mitoses seemed normal and a subset of Cep63 siRNA-injected cells displayed enlargement without intervening mitoses consistent with mitotic skipping (Fig. 3A ; Supplementary Video S1). Quantification in 478 injected cells revealed a highly significant decrease of the mitotic rate because of Cep63 depletion (P ¼ 4.44E-13; Fig. 3B) . Instead, the proportion of cells remaining in interphase was highly significantly elevated compared with cells injected with luciferase-siRNA (P ¼ 1.82E-06; Fig. 3B ). Whereas proliferation resulted in an increased amount of control cells, the number of Cep63-depleted cells remained stable during the experiments (Fig. 3C) . Consistent with mitotic skipping leading to endopolyploidization, Cep63-depleted cells remaining in interphase during observation showed a highly significant increase in cell size (P ¼ 1.19E-06) whereas luciferasesiRNA-injected controls remaining in interphase displayed a stable size (Fig. 3D) . Notably, 22.7% of all Cep63-siRNAinjected cells compared with 2.4% of luciferase-siRNAinjected cells (P ¼ 1.12E-11) showed a more than 1.5-fold size increase while remaining in interphase, indicating that after direct microinjection of Cep63-siRNA, the proportion of cells becoming polyploid is substantially higher than after conventional siRNA transfection.
Mitotic skipping was further confirmed by live imaging of microinjected cells released from a thymidine block revealing that 203 of 320 cells injected with luciferase-siRNA (63%), but only 57 of 265 cells injected with Cep63-siRNA (22%), passed through mitosis as expected between 6 and 24 hours after release (P ¼ 3.02E-24). In addition, Cep63-siRNAinjected U2OS cells stably expressing GFP-a-tubulin allowing visualization of mitotic spindles showed no evidence of mitotic aberrations during live imaging ( Supplementary Fig. S3F ), and quantification on fixed cells revealed a proportion of 89.8% AE 6.1% (mean AE SD of 4 times 100 mitoses) normal bipolar mitoses in U2OS cells 72 hours after transfection with Cep63-siRNA as compared with 96.0%AE1.4% after control siRNA (P ¼ 0.13). Overall, several complementary approaches show that Cep63 depletion leads to inhibition of mitotic entry, with subsequent polyploidization due to endoreplication in a subset of cells, and without inducing significant mitotic aberrations.
Cep63 recruits Cdk1 to the centrosome
Mitosis is initiated by activation of centrosomal cyclin B1-Cdk1 (19, 21) . Lack of Cdk1 activation is associated with skipping of mitosis and endoreplication (23, 34) . Hence, we asked whether mitotic skipping in Cep63-depleted cells reflects lack of centrosomal Cdk1. Immunofluorescence revealed a pronounced decrease of the centrosomal Cdk1 load after Cep63 downregulation in U2OS cells (Fig. 4A and B) . Giant cells observed after Cep63-siRNA showed notably low levels of centrosomal Cdk1, consistent with the model that polyploidization after Cep63 depletion results from a lack of centrosomal Cdk1 (Fig. 4A) . A direct interaction between Cep63 and Cdk1 was verified by both coimmunoprecipitation and an in vitro GST pulldown assay using GST-tagged full-length Cep63 (Fig. 4C and D) . Interestingly, coimmunoprecipitation failed to reveal any evidence for an interaction between Cep63 and cyclin B, A, or E ( Supplementary Fig. S4A ). Finally, siRNAmediated depletion of Cdk1 led to a polyploidization phenotype virtually identical to that observed after Cep63 depletion ( Supplementary Fig. S4B ). We conclude that initiation of mitosis requires centrosomal recruitment of Cdk1 by Cep63.
Cep63 overexpression induces de novo centrosome amplification in interphase
We observed increased numbers of cells with supernumerary centrosomes both after transient overexpression of GFP-Cep63 (Supplementary Fig. S5A ) and in U2OS cells conditionally expressing GFP-Cep63, where centrosome amplification was detectable by 24 to 48 hours and reached a maximum about 72 hours after GFP-Cep63 induction, when a steady state was reached, presumably due to elimination of cells with amplified centrosomes (Fig. 5A and B) . To rule out secondary centrosome amplification due to polyploidization, we induced GFP-Cep63 for up to 2 weeks, but no evidence for polyploidization was found (Supplementary Fig. S5B ). Time-lapse video microscopy revealed that Cep63 overexpression was associated with centrosome amplification occurring during interphase ( Fig. 5C ; Supplementary Video S2). Regularly, gradual accumulation of supernumerary centrosomes in a single interphase was Figure 4 . Cep63 recruits Cdk1 to the centrosome. A, U2OS cells were transfected with siRNA to luciferase (Luc) or Cep63, respectively, fixed after 72 hours, and immunostained for g-tubulin (green) and Cdk1 (red). DNA was counterstained with DAPI (blue). Scale bars, 10 mm. B, in U2OS cells processed as in A, the centrosomal load of the respective protein was quantified in 50 cells per data bar. ***, this difference is highly significant (P ¼ 0.000028). C, immunoprecipitation (IP) from 2 mg protein extract per lane of U2OS cells induced to express GFP-Cep63 or U2OS cells transfected with empty pEGFP-C1 plasmid was conducted with antibodies to the indicated protein, followed by immunoblotting using antibodies to Cep63 (first row), Cdk1, or GFP (fourth and fifth rows), respectively. D, GST pulldown assays with in vitro translated 35 S-Cdk1 and GST or GST-Cep63, respectively. As input control, 10% of the amount of 35 S-Cdk1 used for each pulldown was loaded.
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Cancer Res; 71(6) March 15, 2011 Cancer Researchfollowed by a normal bipolar mitosis, which is consistent with centrosomal clustering preventing spindle multipolarity (15, 16, 35) . The daughter cells resulting from these mitoses often harbored amplified centrosomes as well ( Fig. 5C ; Supplementary Video S2). During Cep63 overexpression, the number of centrin signals often exceeded twice the number of GFP-Cep63 signals, indicating that centriole overduplication preceded maturation with recruitment of Cep63 to overduplicated centrosomes (Fig. 5D) . Amplified centrosomes were associated with only one signal of Cep170, a marker of mature centrioles (36), further confirming de novo centrosome amplification during interphase (Fig. 5D) .
As Cdk inhibition by roscovitine suppressed centrosome amplification upon induction of GFP-Cep63 (Fig. 5B) , we asked whether this phenotype was mediated by Cdk1 or Cdk2. Since Figure 5 . Cep63 overexpression induces de novo centrosome amplification in interphase. All experiments were carried out with U2OS cells conditionally expressing GFP-Cep63. Centrosomes were identified and counted by g-tubulin immunostaining. A, cells were induced to express GFP-Cep63 for the indicated times (dark gray bars) or were left untreated and harvested simultaneously (light gray bars). Parental U2OS cells were grown for 24 hours (white bar). At least 3 times, 100 cells per data bar were evaluated. Top, a representative cell where GFP-Cep63 expression was induced for 72 hours immunostained for g-tubulin (red). DNA was counterstained with DAPI (blue). Scale bars, 10 mm. Insets show higher magnifications of centrosomes. B, where indicated, cells were induced to express GFP-Cep63 for 72 hours, with or without simultaneous addition of roscovitine to a final concentration of 1 mg/mL. Ten times 100 cells per data bar were evaluated. ***, this difference is highly significant (P ¼ 0.00012). *, this difference is significant (P ¼ 0.026). n.s., this difference is not significant (P ¼ 0.071). C, following induction of GFP-Cep63 expression for the indicated times (hours: minutes), GFP fluorescence was monitored by time-lapse microscopy (Supplementary Video S2). A representative example is marked by arrows. Originating from one mother cell, both daughter cells show de novo centrosome amplification in interphase followed by mitoses, with supernumerary centrosomes in their daughter cells as well. A centrosome before (*) and after (**) amplification, as marked in the main panel, is shown enlarged below. It should be noted that the number of GFP-Cep63 signals can be used as a marker of the centrosome number (Fig. 1D) . D, confocal images of centrosomes in U2OS cells conditionally expressing GFP-Cep63 immunostained for centrin (red; top and middle) or Cep170 (red; bottom). Transgene expression was induced for 72 hours. Scale bars, 1 mm. Cdk1 overexpression induced centrosome amplification (Supplementary Fig. S5C ), centrosomal overrecruitment of Cdk1 likely plays a role in Cep63-induced centrosome amplification. On the other hand, coimmunoprecipitation indicated that Cep63 also interacts with Cdk2, although weaker than with Cdk1 ( Supplementary Fig. S5D ). Hence, we cannot exclude that Cdk2 contributes to this phenotype as well. However, we were unable to confirm a direct interaction with Cdk2 in an in vitro GST pulldown assay using GST-Cep63.
The N-terminus of Cep63 is necessary and sufficient for its centrosomal localization and centrosome amplification Using GFP-tagged deletion constructs of Cep63, we found that the N-terminus comprising amino acids 1 to 290 was necessary and sufficient to promote both the centrosomal localization of Cep63 and centrosome amplification (Supplementary Fig. S6 ). Our data indicate that Cep63-induced centrosome amplification depends on the centrosomal localization of Cep63 and that the common N-terminus of all 4 known isoforms of Cep63 consisting of amino acids 1 to 309 ( Supplementary Fig. S1 ) harbors the minimal functional sequence of Cep63.
Cep63 overexpression is associated with aggressive malignancies and promotes chromosomal breakage
Since Cdk deregulation and centrosome amplification are likely oncogenic mechanisms, we speculated that Cep63 might be overexpressed in malignant cells. Indeed, analysis of mRNA expression data of 244 human neuroblastomas revealed a correlation between high Cep63 expression levels and advanced stage (stage 4) of the disease (Fig. 6A) . Moreover, high Cep63 levels were associated with MYCN oncogene amplification and poor survival ( Fig. 6A and B) .
In addition to Cdk-dependent centrosome amplification, Cep63-triggered Cdk deregulation might also impair the DNA damage response and lead to persistence of unrepaired replication-associated defects in the form of DNA DSBs in mitotic cells (37) (38) (39) . We therefore evaluated whether DSB signaling and frequency might be enhanced in Cep63-overexpressing cells exposed to replication stress. Indeed, treatment with aphidicolin, which induces DNA DSBs by inhibiting DNA polymerases (40) , led to an increase in the amount of g-H2AX, a DSB marker, in metaphases of Cep63-overexpressing as compared with control cells (Fig. 6C) . We conclude that Cep63 overexpression is associated with aggressive malignancies, wherein it might contribute to the aggressive behavior of these tumors by impairing the DNA damage response and propagation of unrepaired chromosomal breaks. 
Discussion
In this study, we show that human Cep63 is a constitutive centrosomal protein exhibiting a virtually exclusive centrosomal localization throughout the cell-cycle independent of the presence of microtubules. We show that Cep63 directly interacts with and thereby recruits Cdk1 to centrosomes as a prerequisite for mitotic entry. Moreover, we show that Cep63 overexpression leads to de novo centrosome amplification and a link between Cep63 overexpression to aggressive malignancies and an impaired DNA damage response has been established.
Cdk1 localizes to centrosomes throughout the cell cycle where initial activation of the cyclin B1-Cdk1 complex and subsequent initiation of mitosis occurs (19, 21, 41 ). Cdk2 has been described to localize to centrosomes as well (42) . Cyclins A, B1, and E are recruited to centrosomes independently of Cdks via their centrosomal localization signals, the centrosomal binding partners of which are currently unknown (24, 43) . Consequentially, it is believed but unproven that Cdks are indirectly targeted to centrosomes via their partner cyclins. Our data for the first time provide evidence that Cdk1 is directly recruited to centrosomes via interaction with Cep63. Support for this contention is mani fold: First, we show that Cep63 and Cdk1 directly interact with each other whereas no interaction between cyclins and Cep63 was found. Second, knockdown of Cep63 by siRNA led to a specific depletion of Cdk1 from centrosomes and phenocopied direct knockdown of Cdk1 with mitotic skipping and polyploidization.
In a study on Xenopus mitotic egg extracts, Cep63 downregulation induced aberrant mitoses, which was explained by a lack of centrosomal Cep63 causing inhibition of spindle assembly during mitosis (26) . In mammalian cells, we now describe that Cep63 depletion suppressed mitotic entry altogether, which led to mitotic skipping in a subset of cells. This phenotype was not associated with abnormal mitoses since in cells where Cep63 was efficiently downregulated, G 2 phase was directly followed by endoreplication. However, analogous to the situation in Xenopus mitotic egg extracts, depletion of Cep63 prevented successful cell division in mammalian cells.À s further evidence for a functionally relevant interaction between Cep63 and Cdk1, we show that Cep63 overexpression leads to de novo centrosome amplification during interphase. We have shown that centrosome amplification can be induced by Cdk1 overexpression and Cep63-induced centrosome amplification can be suppressed by roscovitine, and published evidence suggests that Cdk2 is dispensable for centrosome duplication and amplification (14, 44) , which together support the notion that overrecruited Cdk1 contributes to Cep63-induced centrosome amplification. A weak interaction between Cep63 and Cdk2, as indicated by our coimmunoprecipitation data, might additionally contribute to centrosome amplification when Cep63 is overexpressed also because Cdk1 and Cdk2 are closely related in structure (45) . We conclude that the interaction of Cdk1 with Cep63 sufficiently explains all observed phenotypes whereas the potential functional link between Cep63 and Cdk2 remains speculative.
Finally, we show an association of Cep63 overexpression with aggressive behavior of human neuroblastomas and an impaired DNA damage response to replication stress, a condition shared by many oncogene-transformed cells and the majority of human neoplasms (37) (38) (39) . The increased rate of DNA DSBs we observed in the presence of aphidicolin might be explained by elevated Cep63 causing Cdk hyperactivation and, consequently, an override of checkpoint mechanisms that normally guard against mitotic entry with unrepaired chromosomes. In broad terms, this phenotype resembles other types of Cdk deregulation such as Chk1 inhibition or overexpression of the oncogenic Cdc25A phosphatase (46, 47). An alternative mechanism about how overexpressed Cep63 contributes to malignant phenotypes may be centrosome amplification leading to chromosomal instability by promoting chromosome missegregation (17) . Specifically relating to MYC oncogene, it has been shown that MYCN overexpression in neuroblastoma cells induces centrosome hyperamplification after induction of DNA DSBs (48) .
In summary, our data identify Cep63 as a centrosomal recruitment factor for Cdk1 and may help to better understand both the centrosomal regulation of mitotic entry and the phenomenon of centrosome amplification, which is common in malignant cells, presumably underlying cancer-associated chromosomal instability (7, 17) . In addition, Cep63-induced centrosome amplification might be part of the centrosome inactivation checkpoint, a proposed backup checkpoint mechanism promoting mitotic catastrophe (2, 7, (9) (10) (11) (12) . Moreover, we identify a link between Cep63, oncogenesis, and the DNA damage response in human cells, which extends and complements the established role of Cep63 in the regulation of centrosome-dependent spindle assembly after DNA DSBs in Xenopus (26).
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